These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 25589666)
1. Colonic mucosal a-synuclein lacks specificity as a biomarker for Parkinson disease. Visanji NP; Marras C; Kern DS; Al Dakheel A; Gao A; Liu LW; Lang AE; Hazrati LN Neurology; 2015 Feb; 84(6):609-16. PubMed ID: 25589666 [TBL] [Abstract][Full Text] [Related]
2. Detection of alpha-synuclein conformational variants from gastro-intestinal biopsy tissue as a potential biomarker for Parkinson's disease. Ruffmann C; Bengoa-Vergniory N; Poggiolini I; Ritchie D; Hu MT; Alegre-Abarrategui J; Parkkinen L Neuropathol Appl Neurobiol; 2018 Dec; 44(7):722-736. PubMed ID: 29676021 [TBL] [Abstract][Full Text] [Related]
3. Detection of alpha-synuclein aggregates in gastrointestinal biopsies by protein misfolding cyclic amplification. Fenyi A; Leclair-Visonneau L; Clairembault T; Coron E; Neunlist M; Melki R; Derkinderen P; Bousset L Neurobiol Dis; 2019 Sep; 129():38-43. PubMed ID: 31078683 [TBL] [Abstract][Full Text] [Related]
4. Is alpha-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases. Shannon KM; Keshavarzian A; Dodiya HB; Jakate S; Kordower JH Mov Disord; 2012 May; 27(6):716-9. PubMed ID: 22550057 [TBL] [Abstract][Full Text] [Related]
5. Alpha-synuclein in gastric and colonic mucosa in Parkinson's disease: Limited role as a biomarker. Chung SJ; Kim J; Lee HJ; Ryu HS; Kim K; Lee JH; Jung KW; Kim MJ; Kim MJ; Kim YJ; Yun SC; Lee JY; Hong SM; Myung SJ Mov Disord; 2016 Feb; 31(2):241-9. PubMed ID: 26686342 [TBL] [Abstract][Full Text] [Related]
6. Colonic mucosal α-synuclein lacks specificity as a biomarker for Parkinson disease. Ruffmann C; Parkkinen L Neurology; 2015 Sep; 85(9):834. PubMed ID: 26324865 [No Abstract] [Full Text] [Related]
7. Colonic mucosal α-synuclein lacks specificity as a biomarker for Parkinson disease. Woulfe JM; Gray MT; Munoz G Neurology; 2015 Sep; 85(9):834. PubMed ID: 26554094 [No Abstract] [Full Text] [Related]
8. Alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson's disease biomarker. Visanji NP; Marras C; Hazrati LN; Liu LW; Lang AE Mov Disord; 2014 Apr; 29(4):444-50. PubMed ID: 24375496 [TBL] [Abstract][Full Text] [Related]
9. No enhanced (p-) α-synuclein deposition in gastrointestinal tissue of Parkinson's disease patients. Harapan BN; Frydrychowicz C; Classen J; Wittekind C; Gradistanac T; Rumpf JJ; Mueller W Parkinsonism Relat Disord; 2020 Nov; 80():82-88. PubMed ID: 32971383 [TBL] [Abstract][Full Text] [Related]
10. Similar α-Synuclein staining in the colon mucosa in patients with Parkinson's disease and controls. Antunes L; Frasquilho S; Ostaszewski M; Weber J; Longhino L; Antony P; Baumuratov A; Buttini M; Shannon KM; Balling R; Diederich NJ Mov Disord; 2016 Oct; 31(10):1567-1570. PubMed ID: 27324838 [TBL] [Abstract][Full Text] [Related]
11. Analysis of colonic alpha-synuclein pathology in multiple system atrophy. Pouclet H; Lebouvier T; Coron E; Rouaud T; Flamant M; Toulgoat F; Roy M; Vavasseur F; Bruley des Varannes S; Neunlist M; Derkinderen P Parkinsonism Relat Disord; 2012 Aug; 18(7):893-5. PubMed ID: 22560049 [TBL] [Abstract][Full Text] [Related]
15. Nigrostriatal 6-hydroxydopamine lesions increase alpha-synuclein levels and permeability in rat colon. Cui H; Elford JD; Alitalo O; Perez-Pardo P; Tampio J; Huttunen KM; Kraneveld A; Forsberg MM; Myöhänen TT; Jalkanen AJ Neurobiol Aging; 2023 Sep; 129():62-71. PubMed ID: 37271045 [TBL] [Abstract][Full Text] [Related]
16. Oxidative and nitrative alpha-synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathies. Schildknecht S; Gerding HR; Karreman C; Drescher M; Lashuel HA; Outeiro TF; Di Monte DA; Leist M J Neurochem; 2013 May; 125(4):491-511. PubMed ID: 23452040 [TBL] [Abstract][Full Text] [Related]
17. Accumulation of α-synuclein in the bowel of patients in the pre-clinical phase of Parkinson's disease. Hilton D; Stephens M; Kirk L; Edwards P; Potter R; Zajicek J; Broughton E; Hagan H; Carroll C Acta Neuropathol; 2014 Feb; 127(2):235-41. PubMed ID: 24240814 [TBL] [Abstract][Full Text] [Related]